These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 15715487
21. Antiretrovirus specificity and intracellular metabolism of 2',3' -didehydro-2',3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324. Balzarini J, Egberink H, Hartmann K, Cahard D, Vahlenkamp T, Thormar H, De Clercq E, McGuigan C. Mol Pharmacol; 1996 Nov; 50(5):1207-13. PubMed ID: 8913352 [Abstract] [Full Text] [Related]
25. Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region. Velázquez S, Tuñón V, Jimeno ML, Chamorro C, De Clercq E, Balzarini J, Camarasa MJ. J Med Chem; 1999 Dec 16; 42(25):5188-96. PubMed ID: 10602704 [Abstract] [Full Text] [Related]
26. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. Guillemont J, Pasquier E, Palandjian P, Vernier D, Gaurrand S, Lewi PJ, Heeres J, de Jonge MR, Koymans LM, Daeyaert FF, Vinkers MH, Arnold E, Das K, Pauwels R, Andries K, de Béthune MP, Bettens E, Hertogs K, Wigerinck P, Timmerman P, Janssen PA. J Med Chem; 2005 Mar 24; 48(6):2072-9. PubMed ID: 15771449 [Abstract] [Full Text] [Related]
33. First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. Huang B, Liu X, Tian Y, Kang D, Zhou Z, Daelemans D, De Clercq E, Pannecouque C, Zhan P, Liu X. Bioorg Med Chem Lett; 2018 May 01; 28(8):1348-1351. PubMed ID: 29534929 [Abstract] [Full Text] [Related]
35. Synthesis of 6-(3,5-dichlorobenzyl) derivatives as isosteric analogues of the HIV drug 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil (GCA-186). Sørensen ER, El-Brollosy NR, Jørgensen PT, Pedersen EB, Nielsen C. Arch Pharm (Weinheim); 2005 Jul 01; 338(7):299-304. PubMed ID: 15996003 [Abstract] [Full Text] [Related]
36. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Andries K, Azijn H, Thielemans T, Ludovici D, Kukla M, Heeres J, Janssen P, De Corte B, Vingerhoets J, Pauwels R, de Béthune MP. Antimicrob Agents Chemother; 2004 Dec 01; 48(12):4680-6. PubMed ID: 15561844 [Abstract] [Full Text] [Related]
38. Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells. Okamoto M, Makino M, Yamada K, Nakade K, Yuasa S, Baba M. Antiviral Res; 1996 Jun 01; 31(1-2):69-77. PubMed ID: 8793010 [Abstract] [Full Text] [Related]